Boehringer Ingelheim develops breakthrough therapies that change people’s lives today and for generations to come. Research is at the core of the company’s work. Boehringer Ingelheim creates value through innovation in areas where there is currently no satisfactory treatment. Founded in 1885, the family-owned company Boehringer Ingelheim is focused on the long term. More than 52,000 employees work in more than 130 countries across three business areas: human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.
Request a call
